IDA only vs Sweden: Access to anti-retroviral drugs, male
IDA only
80.4%
in 2024
Sweden
95.0%
in 2022
IDA only rank
4th
Sweden rank
4th
Access to anti-retroviral drugs, male over time
- IDA only
- Sweden
How they compare
Sweden currently reports 95.0% against 80.4% in IDA only, a difference of 14.6%.
That makes Sweden's figure about 1.2 times IDA only's.
Across all 23 years both countries report, Sweden has been ahead every year.
IDA only ranks 4th and Sweden ranks 4th of 19 groups.
Sweden has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA only | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.7% | 53.7% | 48.0% | Sweden |
| 2010s | 39.9% | 92.5% | 52.6% | Sweden |
| 2020s | 69.3% | 95.3% | 26.1% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, IDA only or Sweden?
- Sweden, at 95.0% against 80.4% in IDA only as of 2022.
- What is the difference in access to anti-retroviral drugs, male between IDA only and Sweden?
- 14.6%, with Sweden ahead.
- How many years of comparable data are there for IDA only and Sweden?
- 23 years are reported by both, from 2000 to 2022.
- How do IDA only and Sweden rank globally for access to anti-retroviral drugs, male?
- IDA only ranks 4th and Sweden ranks 4th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.